INTRODUCTION
============

Inflammation is natural immune reaction of the body that results from an infection, injury, or illness. Inflammation has been shown to be one of the causes of coronary artery disease [@B002] and arthritis. Nitric oxide has many functions in the body as a vasodilator and neurotransmitter [@B006], and is an important biomarker of the inflammatory response [@B003]. Also, phospholipase A~2~, the enzyme that cleaves membrane phospholipids, was found to be increased through inflammation and in the presence of various inflammatory diseases [@B008]. The medicinal and nutritional uses of honeybee and other hive products including honeybee larva, are well known [@B005]. Bumblebees (e.g. *B. igitus*, *B. terrestris* and *B. h. sapporoensis*) are mass-produced worldwide for use as pollinators. We endeavored to make a safe and effective bumblebee alcohol extracts, and tested its anti-inflammation activity by determining NO production in endothelial cells and phospholipase A~2~ activity, furthermore, various bumblebee extracts were applied to the animal inflammation model-paw edema experiment.

MATERIALS AND METHODS
=====================

***Materials.*** The dried larvae (500 g) of *B. ignitus* (BIL) were soaked and extracted three times with ethanol by ultrasonification for 30 min. The extracts obtained were dried using a rotary evaporation and were freeze-dried as an alcohol extracts of *B. ignitus*. Also, *B. ignitus* pupae (BIP), clony shell of *B. ignitus* (BIC), clony of *B. h. sapporoensis* (BHSPL), BTQ (Queen of *B. terrestris*), and Queen of *B. ignitus* (BIQ) were soaked and extracted according to the method above, respectively. The extracts were obtained using a rotary evaporation and were freeze-dried as alcohol extracts of each bumblebee products.

***Test preparation of bumblebee product extracts.*** Dried alcohol extracts of bumblebee product were homogenized in a blender to a powder, stored at 4℃, dissolved in phosphate buffered saline from Sigma-Aldrich (St. Louis, MO, USA), and were then orally administered to SD rats at doses of 10 mg/kg daily, over 8 days.

***Analysis of mineral content and amino acid composition.*** Mineral contents were analyzed by atomic absorption spectroscopy and phosphorus contents were determined by colorimetric method, which utilizes ammonium molybdate, hydroquinone, and sodium sulfate [@B004]. Amino acid compositional analysis was carried out by derivatization of the first N-terminal amino acids with phenylisothiocyanate (PITC) followed by RP-HPLC [@B009].

***Animals.*** Specific pathogen free SD rats (6 weeks old, weighing 204.6 ± 2.1 g, male), purchased from Samtako Co. Ltd. (Osan, Korea), were housed in an environmentallycontrolled room with 23 ± 1℃, relative humidity of 55 ± 10%, air ventilation of 10\~18 air changes/hr, a 12-hr light/ dark cycle of 150\~300 lux, and feed and water were available *ad libitum*. Rats were kept for one week under normal conditions above and were fed with a standard diet (Samtako Co. Ltd., Osan, Korea), before repeated-dose anti-inflammatory study testing began.

***Anti-inflammatory rat experiment.*** Complete Freund's adjuvant (CFA, Sigma Co., USA) was used to induce rat paw edema at 1^st^ day (pre-treatment) except control group in a chronic arthritis experimental model, and the antiedema effect of individual solvent extracts (post-treatment) was compared.

Rats were divided into 9 groups (n = 7 per group): control group, CFA (100 mM) only treated group (negative control), indomethacin (5 mg/kg at 1^st^ day, 1 mg/kg at 2\~8^th^ day) as a positive control, sample groups \[bumblebee ethanol extracts (each ethanol extract of BIL, BIP, BIC, BHSPL, BTQ, and BIQ)\] daily treated intraperitoneal, over 8 days. Paw size was measured 1, 3, 5 hr and thereafter every day for 14 days using a digital caliper (digimatic, Mitutoyo, Co., Japan).

###### 

Yield and chemical composition of various bumblebee extracts used in this study

  ---------------------------- ------- ------- ------- ------- --------
  Sample                               BIC     BHSPL   BTQ     BIQ
                                                               
  Yield (%)                            3.8     17.6    2.4     7.5
  Fat (%)                              14.19   4.05    4.80    14.19
  Preotein (%)                         12.61   10.78   17.23   35.13
  Ash (%)                              2.37    2.45    5.63    7.05
  Ca (%)                               0.02    0.03    0.03    0.05
  P (%)                                0.42    0.42    1.37    1.65
  K (%)                                0.65    0.65    1.60    2.15
  Na (%)                               0.1     0.1     0.16    0.24
  Mg (%)                               0.05    0.05    0.03    0.04
  Fe (ppm)                             31.40   31.40   88.88   171.17
  Mn (ppm)                             2.19    2.19    2.98    8.87
  Zn (ppm)                             33.20   33.20   51.34   53.31
  Cu (ppm)                             9.35    9.35    12.30   28.07
  Amino acid composition (%)   Cys     0.094   0.063   0.094   0.120
  Met                          0.032   0.098   0.232   0.427   
  Asp                          0.273   0.339   0329    1.523   
  Thr                          0.123   0.207   0.230   0.868   
  Ser                          0.155   0.226   0.247   0.761   
  Glu                          0.478   0.960   1.469   3.479   
  Gly                          0.261   0.378   0.451   1.335   
  Ala                          0.195   0.387   0.704   1.456   
  Val                          0.189   0.360   0.316   1.045   
  Ile                          0.114   0.221   0.250   0.935   
  Leu                          0.198   0.383   0.414   1.690   
  Tyr                          0.055   0.211   0.064   0.359   
  Phe                          0.069   0.177   0.137   0.616   
  Lys                          0.103   0.213   0.380   1.505   
  His                          0.052   0.143   0.161   0.317   
  Arg                          0.058   0.141   0.408   0.726   
  Pro                          0.629   0.900   0.562   1.422   
  ---------------------------- ------- ------- ------- ------- --------

BIC: clony shell of *B. ignitus* extract, BHSPL: clony of *B. h. sapporoensis* extract, BIQ: Queen of *B. ignitus* extract, BTQ: Queen of *B. terrestris* extract.

Seven male rats in each group were weighed and were administered with bumblebee alcohol extracts at a dose of 10 mg/kg or its vehicle a consecutive dose, over a 8 days. The test parameters were paw edema, cytokine interlukin 6 production level, secretory phospholipase A~2~ activity and histopathological findings of dorsal root ganglias, articular cartilage and bone of paw edema rats.

***Nitrite assay.*** The production of NO was measured as the nitrites that accumulated in the culture medium after colorimetric reaction with Griess reagent according to the manufacturer's manual (Cayman Chemicals, Ann Arbor, MI, USA). In brief, samples (200 mg/ml, 20 μl, dilution factor 10) were collected 24 hr after treatment with cultured bovine vascular endothelial (CPAE) cells.

The absorbance at 540 nm was measured with a VERSAmax microplate reader (Molecular Devices, Menlo Park, CA, USA). The cytotoxicities of the purified fractions were tested against the CPAE cell line using XTT {sodium 3\'-\[1-(phenylamino-carbonyl)-3,4-tetrazolium\]-bis(4-methoxy-6- nitro) benzene sulfonic acid hydrate} kit solution (Boehringer Mannheim), as described previously [@B001].

![Anti-inflammatory effect of various bumble bee extract treatment on CFA-induced paw edema in rats. *B. ignitus* pupae extract (BIP), clony shell of *B. ignitus* extract (BIC), clony of *B. h. sapporoensis* extract (BSHPL), Queen of *B. terrestris* extract (BTQ), and Queen of *B. ignitus* extract (BIQ), 10 mg/kg, respectively.](toxicr-28-249-g001){#F001}

***Secretory phospholipase A~2~ measurements in CPAE cells.*** Phospholipase A~2~ cleaves membrane phospholipids to release arachidonic acid, and is the precursor to a large family of pro-inflammatory eicosanoids [@B007]. The secretory phospholipase A~2~ (sPLA~2~) levels in these 24 hrincubated bumblebee extracts were measured by ELISA using a sPLA~2~ assay kit purchased from Cayman Chemicals (Ann Arbor, MI, USA).

![Histopathological data of dorsal root ganglion treated with bumblebee extracts.](toxicr-28-249-g002){#F002}

###### 

Histopathological finding of the LV dorsal root ganglion (DRG) including articular cartilage treated various bumblebee extracts (10mg/kg) on 14^th^ day

  ------- -------------------- ---------------------------------- -------------------------------------------------
  Group   Pathologic finding                                      
                                                                  
  1       Con                                                     
  2       CFA                  Induced injury without treatment   Destruction with erosion of articular cartilage
  3       BIL                  Induced injury with treatment      Repair, incomplete with residual damaged area
  4       BIP                  Induced injury with treatment      Repair, incomplete with residual damaged area
  5       BIQ                  Induced injury with treatment      Repair
  6       BTQ                  Induced injury with treatment      Repair, incomplete with residual damaged area
  7       IND                  Induced injury with treatment      Repair, incomplete with residual damaged area
  8       BHSPL                Induced injury with treatment      Repair, incomplete with residual damaged area
  9       BIC                  Induced injury with treatment      Repair, incomplete with residual damaged area
  ------- -------------------- ---------------------------------- -------------------------------------------------

*B. ignitus* pupae extract (BIP), clony shell of *B. ignitus* extract (BIC), clony of *B. h. sapporoensis* extract (BHSPL), Queen of *B. terrestris* extract (BTQ), and Queen of *B. ignitus* extract (BIQ).

***Histopathology.*** The lumbar V (LV) dorsal root ganglion, including articular cartilage and near leg bones, were dissected from the rats and were fixed in phosphate-buffered formalin. The spinal cords of the rats, including the bone and articular cartilage, were also excised and fixed. After paraffin embedding, they were stained with hematoxylin and eosin, and were analyzed with microscopy.

***Statistical analysis.*** Mean and standard errors of all parameters were determined for each of the 8 rats. The Student's *t*-test was used to establish the significances of differences between the control and treatment groups. *p* \< 0.05 was considered statistically significant.

###### 

Histopathologic finding of the spinal cord, including articular cartilage and bones, treated with various bumblebee extracts in CFA-induced arthritis rat model on 14^th^ day

  ------------------ --------------------------------- -------------------------------------------- -----------------------------------------------
  Group              Pathologic finding                                                             
                                                                                                    
  1\. Control                                                                                       Normal
  2\. CFA            Control                           Induced injury without treatment             Repair incomplete with residual damaged area
  Control            Opposite site without treatment   Partial destruction of articular cartilage   
  3\. BIL            Treat                             Induced injury with treatment                Repair
  Control            Opposite site without treatment   Partial destruction of articular cartilage   
  4\. BIP            Treat                             Induced injury with treatment                Repair, incomplete with residual damaged area
  Control            Opposite site without treatment   Mildly damaged articular cartilage, focal    
  5\. BIQ            Treat                             Induced injury with treatment                Repair, incomplete with residual damaged area
  Control            Opposite site without treatment   Mildly damaged articular cartilage, focal    
  6\. BTQ            Treat                             Induced injury with treatment                Repair
  Control            Opposite site without treatment   No significant alteration                    
  7\. Indomethacin   Treat                             Induced injury with treatment                Repair
  Control            Opposite site without treatment   Destruction of articular cartilage           
  8\. BHSPL          Treat                             Induced injury with treatment                Repair, incomplete with residual damaged area
  Control            Opposite site without treatment   Partial destruction of articular cartilage   
  9\. BIC            Treat                             Induced injury with treatment                Repair
  Control            Opposite site without treatment   Partial destruction of articular cartilage   
  ------------------ --------------------------------- -------------------------------------------- -----------------------------------------------

^\*^Bumblebee ethanol extracts (10mg/kg), ^\*^Treat: the paw portion with induction of inflammation and sample treatment, Control: the paw portion without induction of inflammation (opposite paw).

RESULTS
=======

***Anti-inflammation.*** We showed that bumblebee alcohol extracts have potential efficacies in treating inflammation in SD rats, as they significantly reduced paw edema levels as the following order: BIQ \> BIC \> BTQ \> BIL, and repaired damaged dorsal root ganglias of CFA adjuvant arthritis.

Six total alcohol extracts, of BIL, BIP, BIQ, BTQ, BHSPL and BIC, were treated to the peritoneum (10 mg/kg) of paw edema induced rats, and the effect of individual extracts was in the following order: BIQ \> BIC \> BTQ \> BIL ([Fig. 1](#F001){ref-type="fig"}). The mean changes in paw edema size (mm) from 1 hr to 14 days for each group were as follows: control (7.54 ± 0.21), CFA (9.86 ± 0.23), BIL (9.11 ± 0.18), BIP (8.81 ± 0.091), BIQ (8.53 ± 0.43), BTQ (8.87 ± 0.13), IND (8.19 ± 0.70), BHSPL (7.96 ± 0.67), BIC (7.95 ± 0.67).

***Articular cartilage destruction repair by bumblebee extracts.*** In the histopathological analysis, bumblebee extracts treatment repaired the LV dorsal root ganglion linked to the edematous paw, including the articular cartilage, against CFA induced cartilage destruction, respectively. This was in contrast to the effects observed in the CFA treated group, where the articular cartilage was destroyed by erosion ([Fig. 2](#F002){ref-type="fig"} and [Table 2](#T002){ref-type="table"}). In the histopathological finding of pathological spinal cord, the bumblebee extract groups, especially BIQ (Queen of *B. igntitus*) extract group, showed anti-edema effects compared to the CFA only treated group ([Table 3](#T003){ref-type="table"}).

***Pro-inflammatory cytokines (secretory PLA~2~ and NO).*** Furthermore, these extracts also had multiple actions such as remarkable NO production in endothelial cells related to vasorelaxation and secretory phospholipase A~2~ activity ([Fig. 4](#F004){ref-type="fig"}). The productions of nitric oxide in the treated groups were also inhibited according to vasorelaxation of blood vessel in the alcohol extract of BTQ, BIC, BIL and BIQ ([Fig. 3](#F003){ref-type="fig"}). There was also no cytotoxicity observed for the bumblebee extracts in XTT assay (data not shown).

![Effects of the various bumble bee extract on nitric oxide production activity in CPAE cells.](toxicr-28-249-g003){#F003}

![Secretory phospholipase A~2~ activity of various bee alcohol extract. \* Sample Conc.: 200mg/ml.](toxicr-28-249-g004){#F004}

DISCUSSION
==========

In order to identify the best bumblebee extracts for the control of inflammation reaction, we made alcohol extracts of the larva, pupa, queen and cocoon of *B. ignitus* and *B. terrestris*, and *B. h. sapporoensis*, and tested their medicinal activities. The anti-inflammatory activity of Hymenoptera, bumblebee alcohol extract was examined by using adjuvant- induced edema and arthritis in rats. In the previous report, *B. ignitus* alcohol extracts did not show acute toxicity at 0.04, 0.2, 1 or 5 g/kg [@B001]. Each alcohol extract from *B. ignites* queens, *B. terrestris* queens and *B. ignites* cocoons, decreased the hind paw edema after 1 day of *ip* administeration. Also, the extracts contributed to vasorelaxation on NO production increases in CPAE cells. These results suggest that bumbleebee alcohol extract has potential as a crude ant-inflammatory drug and vasorelaxation agent. As commercial bee venom, the secretary phospholipase A~2~ levels of queen of *B. ignitus* extract was higher than those of other bumblebee extracts, and had antiinflammatory activity and articular cartilage destruction repair, this is deemed to be the most effective agent for this purpose.
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